1 Enbrel Market Overview

• 1.1 Product Overview and Scope of Enbrel
• 1.2 Enbrel Segment by Type
  • 1.2.1 Global Enbrel Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Brands Drugs
  • 1.2.3 Biosimilar Drugs
• 1.3 Enbrel Segment by Application
  • 1.3.1 Global Enbrel Sales Comparison by Application: (2021-2027)
  • 1.3.2 Rheumatoid Arthritis
  • 1.3.3 Juvenile Idiopathic Arthritis
  • 1.3.4 Psoriatic Arthritis
  • 1.3.5 Ankylosing Spondylitis
  • 1.3.6 Other
• 1.4 Global Enbrel Market Size Estimates and Forecasts
  • 1.4.1 Global Enbrel Revenue 2016-2027
  • 1.4.2 Global Enbrel Sales 2016-2027
  • 1.4.3 Enbrel Market Size by Region: 2016 Versus 2021 Versus 2027

2 Enbrel Market Competition by Manufacturers

• 2.1 Global Enbrel Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Enbrel Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Enbrel Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Enbrel Manufacturing Sites, Area Served, Product Type
• 2.5 Enbrel Market Competitive Situation and Trends
  • 2.5.1 Enbrel Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Enbrel Players Market Share by Revenue
  • 2.5.3 Global Enbrel Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Enbrel Retrospective Market Scenario by Region

• 3.1 Global Enbrel Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global Enbrel Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America Enbrel Market Facts & Figures by Country
  • 3.3.1 North America Enbrel Sales by Country
  • 3.3.2 North America Enbrel Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
• 3.4 Europe Enbrel Market Facts & Figures by Country
  • 3.4.1 Europe Enbrel Sales by Country
  • 3.4.2 Europe Enbrel Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Enbrel Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Enbrel Sales by Region
  • 3.5.2 Asia Pacific Enbrel Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 China Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
• 3.6 Latin America Enbrel Market Facts & Figures by Country
  • 3.6.1 Latin America Enbrel Sales by Country
  • 3.6.2 Latin America Enbrel Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
• 3.7 Middle East and Africa Enbrel Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Enbrel Sales by Country
  • 3.7.2 Middle East and Africa Enbrel Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Enbrel Historic Market Analysis by Type

• 4.1 Global Enbrel Sales Market Share by Type (2016-2021)
• 4.2 Global Enbrel Revenue Market Share by Type (2016-2021)
• 4.3 Global Enbrel Price by Type (2016-2021)

5 Global Enbrel Historic Market Analysis by Application

• 5.1 Global Enbrel Sales Market Share by Application (2016-2021)
• 5.2 Global Enbrel Revenue Market Share by Application (2016-2021)
• 5.3 Global Enbrel Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Amgen
  • 6.1.1 Amgen Corporation Information
  • 6.1.2 Amgen Description and Business Overview
  • 6.1.3 Amgen Enbrel Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Amgen Enbrel Product Portfolio
  • 6.1.5 Amgen Recent Developments/Updates
• 6.2 Pfizer
  • 6.2.1 Pfizer Corporation Information
  • 6.2.2 Pfizer Description and Business Overview
  • 6.2.3 Pfizer Enbrel Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Pfizer Enbrel Product Portfolio
  • 6.2.5 Pfizer Recent Developments/Updates
• 6.3 3SBIO
  • 6.3.1 3SBIO Corporation Information
  • 6.3.2 3SBIO Description and Business Overview
  • 6.3.3 3SBIO Enbrel Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 3SBIO Enbrel Product Portfolio
  • 6.3.5 3SBIO Recent Developments/Updates
• 6.4 Celgen Biopharma
  • 6.4.1 Celgen Biopharma Corporation Information
  • 6.4.2 Celgen Biopharma Description and Business Overview
  • 6.4.3 Celgen Biopharma Enbrel Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Celgen Biopharma Enbrel Product Portfolio
  • 6.4.5 Celgen Biopharma Recent Developments/Updates

7 Enbrel Manufacturing Cost Analysis

• 7.1 Enbrel Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Enbrel
• 7.4 Enbrel Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Enbrel Distributors List
• 8.3 Enbrel Customers

9 Enbrel Market Dynamics

• 9.1 Enbrel Industry Trends
• 9.2 Enbrel Growth Drivers
• 9.3 Enbrel Market Challenges
• 9.4 Enbrel Market Restraints

10 Global Market Forecast

• 10.1 Enbrel Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Enbrel by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Enbrel by Type (2022-2027)
• 10.2 Enbrel Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Enbrel by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Enbrel by Application (2022-2027)
• 10.3 Enbrel Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Enbrel by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Enbrel by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Brands Drugs
Biosimilar Drugs

Segment by Application
Rheumatoid Arthritis
Juvenile Idiopathic Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Amgen
Pfizer
3SBIO
Celgen Biopharma